Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 2/12/2026UniXell Raises Over CNY 50M in Series A+ to Advance Stem Cell Therapy ...
  • 2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
  • 2/11/2026Regend Raises CNY 350M Series C to Advance Cell-Based Organ Regenerati...
  • 2/11/2026TenNor Therapeutics Files for Hong Kong IPO as Dual-Core Antibiotic Pi...
  • 2/11/2026Madrigal Expands MASH Pipeline with Six siRNA Programs from China's Ri...
  • 2/11/2026Sanofi Backs GluBio's Molecular Glue Pill for Sickle Cell Disease
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/10/2026Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
  • 2/10/2026Hengrui and Kailera Advance Obesity Therapy After Encouraging Mid-Stag...
  • 2/10/2026Cascade Raises $72M to Advance MASH, Obesity and Diabetes Pipeline
  • 2/9/2026BioKangtai Cancels Planned Vaccine Joint Venture With AstraZeneca in C...
  • 2/9/2026Lilly Expands China Partnership With Innovent in New Global Oncology a...
  • 2/7/2026Bio‑Thera and Avalon Forge 15‑Year Deal to Bring Keytruda Biosimilar...
  • 2/6/2026Genturn Life Raises CNY Tens of Millions in Angel Round to Advance Re...
  • 2/6/2026DCH Auriga Teams Up with Hengrui to Expand Innovative Medicines in HK ...
  • 2/5/2026Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
  • 2/5/2026Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
  • 2/5/2026Angitia Biopharma Raises $130M in Series D Financing to Advance Pipeli...
  • 2/5/2026Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
  • 2/5/2026iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
  • 2/5/2026Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
  • 2/4/2026Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • 2/4/2026China Gene‑Editing Startup AccurEdit Raises $75M to Advance Promising...
  • 2/4/2026WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
  • 2/3/2026Beijing-Based PrimeGenX Therapeutics' HKSE IPO Application Accepted
  • 2/3/2026New Indication for Novartis' Secukinumab in Non-Radiographic Axial Spo...
  • 2/3/2026Zonsen PepLib Signs Global Peptide R&D Deal with Eli Lilly
  • Page:1/25 Total number of articles:750: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group